As lead co-sponsor of the Marihuana Regulation and Taxation Act (MRTA), which just celebrated its five year anniversary, Majority Leader Peoples-Stokes championed groundbreaking marijuana legalization that prioritized community repair and reinvestment.
We spoke with Cat Packer, Drug Policy Alliance’s Director of Legal Regulation, to answer frequently asked questions about the challenges with high-THC marijuana products and the solutions needed to ensure consumer safety.
What we protected - and built - together in 2025.
Rescheduling marijuana to Schedule III would boost corporate profits and could expand some research, but would maintain criminalization, harmful enforcement, and barriers to health and safety.
Marijuana reform has produced many positive outcomes, new challenges and unintended consequences. Drug Policy Alliance organized a series of focus groups to gather more insights from a wide range of experts.
Leading advocacy organizations detail the Hochul administration mismanagement and present roadmap for fixing cannabis law implementation.
Orgs to Hochul: Leadership Must Change to Reflect Expertise in Cannabis, Economic Market Development, and Regulatory Licensing
This executive order is a model for how administrations can use their authority to transform federal marijuana policies to improve the lives of everyday people — rather than just improving profits for marijuana corporations.
